Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Classifica tra le azioni #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Prezzo delle azioni
$0.71707249
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$94.14M
Variazione (1 giorno)
-3.31%
Variazione (1 anno)
76.82%
Paese
SE
Scambia AlzeCure Pharma AB (ALZCUR)

Categoria

Storico del prezzo dell'azione per AlzeCure Pharma AB (ALZCUR)
Prezzo di chiusura più alto: $0.75 il 2026-08-01

Prezzo di chiusura più basso: $1.08 il 2018-11-01
Storico del prezzo dell'azione di AlzeCure Pharma AB dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 27.37%
2025 118.89%
2024 -63.25%
2023 -21.67%
2022 -38.07%
2021 -40.60%
2020 149.60%
2019 -53.66%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH